Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Howell

Showing results (251-260 of 339) with videos related to

Pageof 34
Sort By:
Cancers|February 13, 2020
Risk of Contralateral Breast Cancer in Women with and without Pathogenic Variants in <i>BRCA1, BRCA2</i>, and <i>TP53</i> Genes in Women with Very Early-Onset (<36 Years) Breast CancerZerin Hyder, Elaine F Harkness, Emma R Woodward, et al.
International Journal of Cancer|September 19, 2002
Survival in prospectively ascertained familial breast cancer: analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomyPål Møller, Ake Borg, D Gareth Evans, et al.
Cell Cycle (Georgetown, Tex.)|February 8, 2013
Cigarette smoke metabolically promotes cancer, via autophagy and premature aging in the host stromal microenvironmentAhmed F Salem, Mazhar Salim Al-Zoubi, Diana Whitaker-Menezes, et al.
Lancet (London, England)|December 22, 2015
Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trialJohn F Forbes, Ivana Sestak, Anthony Howell, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 13, 2022
Reversing the Genomic, Epigenetic, and Triple-Negative Breast Cancer-Enhancing Effects of ObesityLaura W Bowers, Steven S Doerstling, Meghana G Shamsunder, et al.
Cell Cycle (Georgetown, Tex.)|July 18, 2013
Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFκB target stromal MCT4Ubaldo E Martinez-Outschoorn, Joseph M Curry, Ying-Hui Ko, et al.
Cancer Biology & Therapy|December 15, 2010
Caveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment: a new genetically tractable model for human cancer associated fibroblastsCasey Trimmer, Federica Sotgia, Diana Whitaker-Menezes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2004
Adjuvant use of anastrozole in breast cancerJack Cuzick, Aman Buzdar, Michael Baum, et al.
Cell Cycle (Georgetown, Tex.)|December 3, 2011
Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ: visualizing the therapeutic effects of metformin in tumor tissueDiana Whitaker-Menezes, Ubaldo E Martinez-Outschoorn, Neal Flomenberg, et al.
Cell Cycle (Georgetown, Tex.)|September 25, 2010
HIF1-alpha functions as a tumor promoter in cancer associated fibroblasts, and as a tumor suppressor in breast cancer cells: Autophagy drives compartment-specific oncogenesisBarbara Chiavarina, Diana Whitaker-Menezes, Gemma Migneco, et al.
Pageof 34

Showing results (251-260 of 339) with videos related to

Sort By:
Pageof 34
Cancers|February 13, 2020
Risk of Contralateral Breast Cancer in Women with and without Pathogenic Variants in <i>BRCA1, BRCA2</i>, and <i>TP53</i> Genes in Women with Very Early-Onset (<36 Years) Breast CancerZerin Hyder, Elaine F Harkness, Emma R Woodward, et al.
International Journal of Cancer|September 19, 2002
Survival in prospectively ascertained familial breast cancer: analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomyPål Møller, Ake Borg, D Gareth Evans, et al.
Cell Cycle (Georgetown, Tex.)|February 8, 2013
Cigarette smoke metabolically promotes cancer, via autophagy and premature aging in the host stromal microenvironmentAhmed F Salem, Mazhar Salim Al-Zoubi, Diana Whitaker-Menezes, et al.
Lancet (London, England)|December 22, 2015
Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trialJohn F Forbes, Ivana Sestak, Anthony Howell, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 13, 2022
Reversing the Genomic, Epigenetic, and Triple-Negative Breast Cancer-Enhancing Effects of ObesityLaura W Bowers, Steven S Doerstling, Meghana G Shamsunder, et al.
Cell Cycle (Georgetown, Tex.)|July 18, 2013
Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFκB target stromal MCT4Ubaldo E Martinez-Outschoorn, Joseph M Curry, Ying-Hui Ko, et al.
Cancer Biology & Therapy|December 15, 2010
Caveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment: a new genetically tractable model for human cancer associated fibroblastsCasey Trimmer, Federica Sotgia, Diana Whitaker-Menezes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2004
Adjuvant use of anastrozole in breast cancerJack Cuzick, Aman Buzdar, Michael Baum, et al.
Cell Cycle (Georgetown, Tex.)|December 3, 2011
Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ: visualizing the therapeutic effects of metformin in tumor tissueDiana Whitaker-Menezes, Ubaldo E Martinez-Outschoorn, Neal Flomenberg, et al.
Cell Cycle (Georgetown, Tex.)|September 25, 2010
HIF1-alpha functions as a tumor promoter in cancer associated fibroblasts, and as a tumor suppressor in breast cancer cells: Autophagy drives compartment-specific oncogenesisBarbara Chiavarina, Diana Whitaker-Menezes, Gemma Migneco, et al.
Pageof 34